EICHOR
● Terminated
A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS Study).
Condition: Pulmonary Arterial Hypertension · Sponsor: Keros Therapeutics, Inc.
About this study
Study KER-012-A201 is Phase 2, double-blind, randomized, placebo-controlled study to determine the efficacy and safety of KER-012 compared to Placebo in adults with PAH (WHO Group 1 PH) on stable background PAH therapy. The study is divided into the Screening Period, Treatment Period, Extension Period, and Follow-Up Period.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (55)
| TROPOS Study Site 111 | Scottsdale, Arizona, United States | — |
| TROPOS Study Site 107 | Tucson, Arizona, United States | — |
| Site PI TROPOS Study Site 104 | Stanford, California, United States | — |
| TROPOS Study Site 105 | Torrance, California, United States | — |
| TROPOS Study Site 108 | Jacksonville, Florida, United States | — |
| TROPOS Study Site 100 | Kansas City, Kansas, United States | — |
| TROPOS Study Site 110 | Louisville, Kentucky, United States | — |
| TROPOS Study Site 103 | Boston, Massachusetts, United States | — |
| TROPOS Study Site 109 | Boston, Massachusetts, United States | — |
| TROPOS Study Site 101 | Ann Arbor, Michigan, United States | — |
| TROPOS Study Site 115 | St Louis, Missouri, United States | — |
| TROPOS Study Site 114 | Albuquerque, New Mexico, United States | — |
+ 43 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.